Mindfulness Awareness Is Associated With a Lower Risk of Anxiety and Depressive Symptoms in Older Adults With Neurocognitive Disorders by Lam, Linda Chiu Wa et al.
Northumbria Research Link
Citation: Lam, Linda Chiu Wa, Lee, Allen T. C., Cheng, Sheung Tak, Yip, Benjamin H. K.,
Chan, Wai Chi, Fung, Ada W. T., Ma, Suk Ling, Cheng, Calvin P. W., Kong, Ryan, Chiu,
Henry T. S., Lai, Frank H. Y. and Wong, Samuel Yeung Shan (2021) Mindfulness Awareness
Is Associated With a Lower Risk of Anxiety and Depressive Symptoms in Older Adults
With Neurocognitive Disorders. Frontiers in Psychiatry, 12. p. 721583. ISSN 1664-0640 
Published by: Frontiers Media
URL:  https://doi.org/10.3389/fpsyt.2021.721583
<https://doi.org/10.3389/fpsyt.2021.721583>
This  version  was  downloaded  from  Northumbria  Research  Link:
http://nrl.northumbria.ac.uk/id/eprint/47538/
Northumbria University has developed Northumbria Research Link (NRL) to enable users
to access the University’s research output. Copyright © and moral rights for items on
NRL are retained by the individual author(s) and/or other copyright owners.  Single copies
of full items can be reproduced, displayed or performed, and given to third parties in any
format or medium for personal research or study, educational, or not-for-profit purposes
without  prior  permission  or  charge,  provided  the  authors,  title  and  full  bibliographic
details are given, as well as a hyperlink and/or URL to the original metadata page. The
content must not be changed in any way. Full items must not be sold commercially in any
format or medium without formal permission of the copyright holder.  The full policy is
available online: http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been
made available online in accordance with publisher policies. To read and/or cite from the
published version of  the research,  please visit  the publisher’s website (a subscription
may be required.)
                        
ORIGINAL RESEARCH
published: 21 October 2021
doi: 10.3389/fpsyt.2021.721583






University of Bologna, Italy
Ram J. Bishnoi,
Augusta University, United States
*Correspondence:
Linda Chiu Wa Lam
cwlam@cuhk.edu.hk
†Present address:
Frank H. Y. Lai,
Department of Social Work, Education




This article was submitted to
Aging Psychiatry,
a section of the journal
Frontiers in Psychiatry
Received: 07 June 2021
Accepted: 14 September 2021
Published: 21 October 2021
Citation:
Lam LCW, Lee ATC, Cheng ST,
Yip BHK, Chan WC, Fung AWT,
Ma SL, Cheng CPW, Kong R,
Chiu HTS, Lai FHY and Wong SYS
(2021) Mindfulness Awareness Is
Associated With a Lower Risk of
Anxiety and Depressive Symptoms in





Associated With a Lower Risk of
Anxiety and Depressive Symptoms in
Older Adults With Neurocognitive
Disorders
Linda Chiu Wa Lam 1*, Allen T. C. Lee 1, Sheung Tak Cheng 2, Benjamin H. K. Yip 3,
Wai Chi Chan 4, Ada W. T. Fung 5, Suk Ling Ma 1, Calvin P. W. Cheng 4, Ryan Kong 1,
Henry T. S. Chiu 1, Frank H. Y. Lai 6† and Samuel Yeung Shan Wong 3
1Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR China,
2Department of Health and Physical Education, The Education University of Hong Kong, Hong Kong, SAR China, 3 The
Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, SAR China,
4Department of Psychiatry, University of Hong Kong, Hong Kong, SAR China, 5Department of Applied Social Sciences,
Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong, SAR China, 6Department of
Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong, SAR China
Background: Apart from depressive disorders, there are great interests in adopting
mindfulness based interventions (MBIs) for other mental health conditions. Depression
and anxiety are common in people with neurocognitive disorders (NCD). The potential of
MBIs as an adjuvant treatment in this cognitively at-risk group should be further explored.
Objectives: The current study explored the association between depression and anxiety
symptoms with dispositional mindfulness in older adults, and if same association stays
in the context of cognitive impairment.
Methods: The Hong Kong Mental Morbidity Survey for Older People (MMSOP) is an
ongoing epidemiology study of the prevalence of neurocognitive and mental disorders
in adults aged 60 years or over in Hong Kong. MMSOP evaluated cognitive function,
psychiatric symptoms (Clinical Interview Schedule-revised, CIS-R), chronic physical
disease burden, psychosocial support, and resilience factors, including dispositional
mindfulness as measured by the Mindful Attention Awareness Scale (MAAS). We
analyzed the impact of MAAS on CIS-R and potential moderation effects of mindfulness.
Results: In March 2021, 1,218 community dwelling participants completed
assessments. The mean age of the sample is 69.0 (SD 6.9) years. Eight hundred
and two participants (65.7%) were not demented (CDR 0) and 391 (32%) and 25
(2%) were categorized as having mild NCD (CDR 0.5) and major NCD (CDR 1 or
more), respectively. One hundred forty-three (11.7%) satisfied ICD-10 criteria for anxiety
or depressive disorder as measured by CIS-R. Linear regression analysis showed
that female gender, CIRS, and MAAS scores were significant factors associated with
CIS-R scores. MAAS scores moderated and attenuated the impact CIRS on CIS-R
(adjusted R2 = 0.447, p < 0.001). MAAS scores remained as significant moderator
for CIRS in patients with NCD (CDR ≥ 0.5) (adjusted R2 = 0.33, p < 0.001).
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Conclusion: Interim findings of the MMSOP suggested that dispositional mindfulness
is associated with lower level of mood symptoms in community dwelling older adults
in Hong Kong. The interaction effects further suggested that high mindful awareness
may reduce the adverse effects of chronic physical morbidity on mental health. The
observation stayed in the participants with cognitive impairment. We should further
explore MBIs as a non-pharmacological treatment for in older adults at-risk of physical
morbidity and cognitive decline.
Keywords: neurocognitive disorder, dementia, depression, anxiety, dispositional mindfulness
INTRODUCTION
Mindfulness has been a cherished spiritual practice aiming to
achieve a state of serenity in different religions over the world.
The tradition ofmindfulness practice, while described in different
terms, could be tracked back thousands of years. Some key
concepts of dispositional (also referred to as trait) mindfulness
describes a personal attribute in moment-to-moment conscious
awareness of internal and external sensation, own emotional state
with self-regulation of affective response with a non-judgemental
and neutral attitude (1). In the past few decades, considering that
there may be changes in the ability to become more mindful,
mindfulness related practices such as meditation have been
turned into an emerging strategy for the management of mental
and physical health problems.
Mindfulness based interventions (MBIs), based on
mindfulness approach, are enriched with conventional
psychological treatment concepts. MBIs are well-recognized
for its benefits on relapse prevention of recurrent depressive
disorders (2). In a meta-analysis of 1,258 patients with a 60-
week follow up period, those who received mindfulness based
cognitive therapy (MBCT) had a reduced risk for relapse of
depression (hazard ratio, 0.69, 95% CI, 0.58–0.82). There was
also a significant interaction between baseline depression scores
and MBCT treatment effects. A higher baseline depression was
associated with a larger treatment effect (hazard ratio, 0.80, 95%
CI, 0.66–0.97) (3). Apart from mental disorders, the findings of
meta-analyses generally supported positive benefits of MBIs in
pain and cancer-associated mood syndromes, although the effect
sizes and sustainability of benefits are less consistent compared to
recurrent depression (4, 5). In a 12 week randomized controlled
trial of mindfulness vs. waitlist control, MBI demonstrated
large effect size (d = 0.85) on interoceptive awareness and
self-regulation in war veterans with stress-related disorders (6).
The therapeutic mechanisms by which MBIs brought about
better mood and mental health may be diverse. In a review paper
discussing the relationship between mindfulness meditation and
psychopathology, the components of mindfulness practice in the
promoting self-regulation of affect and cognition are examined.
The review offered support for MBIs as an intervention for
different mental disorders when mood and affective regulations
are frequently disrupted (7). Some studies suggested that
older adults who assumed mindfulness practice regularly are
associated with higher cognitive function and less age-related
brain degenerative responses, with the prefrontal, cingulate, and
insular cortex implicated as significant regions of interests (8–10).
It poses a challenging question—Will MBI work only in people
with high cognitive skills? Apart from progressive cognitive
and functional deterioration, depressive and anxiety symptoms
are not only prevalent in people with neurocognitive disorders
(NCD), they also jeopardize life quality and poses risks to patients
and carers. However, meta-analysis studies on antidepressant
treatment in people with dementia and behavioral disturbances
showed variable treatment effects (11, 12). Adjuvant non-drug
measures, including lifestyle modifications, may have a role for
optimization of mood symptoms. In a recent review paper,
the authors examined MBIs and cognitive training in people
with mild NCD. The results suggested preliminary evidence for
positive effects on cognition and mood in this cognitively at-risk
group (13).
Before embarking on the development of MBIs for mood
management in people with NCD, we explored the association
between dispositional mindfulness and mood symptoms in
a randomly recruited community sample of older adults in
Hong Kong. We aimed to address two questions in this
report. First, would dispositional mindfulness be associated with
fewer mood symptoms? Second, would the association between
mindfulness and mood symptoms differ between cognitively
healthy older adults and those with NCD?
METHODS
Participants and Study Design
Subjects recruited in the present report were community
dwelling older participants of the ongoing Hong Kong
Mental Morbidity Survey for Older People (HKMMSOP).
MMSOP is a cross-sectional epidemiological study funded
by the Food and Health Bureau of the Hong Kong SAR.
The main study aims to evaluate the prevalence of NCDs
and mental disorders in older adults in Hong Kong. Data
collection started in 2019, and the target sample size will be
6,000. Potential participants were identified through postal
invitations from random sampling of regional addresses
quarters provided by the Census and Statistics Department.
Selected households with adults at or above 60 years old
interested to participate in the study contacted our research
office for assessments. For each consented participant, we
Frontiers in Psychiatry | www.frontiersin.org 2 October 2021 | Volume 12 | Article 721583
Lam et al. Mindfulness, Mood, and Neurocognitive Disorders
conducted cognitive, mental and physical health, as well
as lifestyle enquiries. The current report represented the
interim findings of the initial 1,500 participants of the
HKMMSOP, from which 1,218 completed the questionnaire on
dispositional mindfulness.
Ethical Considerations
Institutional Review Board approvals have been obtained from
the Survey and Behavioral Research Ethics Committee and
Clinical Research Ethics Committee of the Chinese University
of Hong Kong. Written informed consent was obtained for
all participants of the current report. A brief report of the
assessment results was prepared as his/her personal health
record for each participant. For people with NCD or psychiatric
disorders but not yet assessed under clinical settings, we
prepared written referral letters for further care at appropriate
settings. The study has been registered under China Clinical
Registry (ChiCTR1900024349).
Assessments
Apart from demographic profile, cognitive function, depression
and anxiety symptoms, chronic physical morbidity, dispositional
mindfulness, and sense of loneliness were assessed. Details of the
assessment instruments are listed below.
Basic Demographic Information
• Global Cognition was assessed by the Clinical Dementia
Rating (CDR). CDR is a clinician rated assessment on six areas
of cognition and everyday function, which includes memory,
orientation, judgment and problem solving, community
affairs, home and hobbies, and personal care (14). CDR
determines overall cognition from normal (not-demented,
CDR = 0) to severe dementia (CDR = 3). In the paper, we
adopted a reference with CDR 0.5 for mild NCD and CDR ≥
1 for major NCD.
• The locally validated Hong Kong Montreal Cognitive
Assessment (MoCA) was administrated to determine a global
cognitive function score in the current study (15). The MoCA
is a Chinese validated version of MoCA, which examines
cognitive domains including memory, attention, language,
visuospatial skills, orientation, abstraction, executive function,
and calculation (16). Studies in Hong Kong older population
suggested that MoCA is sensitive in detecting executive
function changes in subcortical vascular NCD, which is highly
prevalent in Chinese population.
• Mood symptoms were evaluated with the Revised Clinical
Interview Schedule (CIS-R) (17, 18). The CIS-R is a structured
psychiatric assessment interview schedule tapping 14 groups
of non-psychotic psychological symptoms in the week prior to
interview. The symptom clusters and scores were integrated
to form ICD-10 diagnoses of six groups of common mental
disorders including generalized anxiety disorder (GAD),
mixed anxiety and depressive disorder, depressive episode,
phobias, obsessive compulsive disorder (OCD), and panic
disorder. A cutoff score of 12 is indicative of syndromal
diagnosis of depressive or anxiety disorders both in the
Chinese and original English versions.
• Chronic disease burden was measured by the Geriatric version
of the Cumulative Illness Disease Raring Scale (CIRS) (19).
CIRS measures morbidity of 14 categories of physical and
psychiatric diseases. A score of 1–4 for each system disease
indicates severity by which a condition affects life and urgency
of treatment. The CIRS-Geriatric version estimated a severity
index to show over disease severity in geriatric population.
• Dispositional mindfulness was measured by the Mindful
Attention Awareness Scale (MAAS) (1). The MAAS is a 15-
item scale used to assess participants’ attention awareness to
present moment experience. MAAS has a score of 1–6, with
higher score indicated higher degree for attention to present
states. MAAS has demonstrated psychometric properties with
a 1-factor structure; it was validated across different cultures
and populations (20, 21).We asked about the practice duration
of mindfulness activities with a questionnaire on leisure
activities. Examples of mindfulness activities included writing
reflective diaries, meditation, quiet sitting, reading religious
texts, and making prayer.
• Subjective loneliness was measured by the Chinese 6-item
De Jong Gierveld Loneliness Scale. The dimensions of social
and emotional loneliness have been identified as important
risk factor for poor mental health in the older population.
The Chinese version has been validated with satisfactory
psychometric properties (22).
Statistical Analyses and Power Estimation
The weighted population prevalence of neurocognitive and
mental disorders in older people will be computed when
the field work of MMSOP has been completed. The current
report is a preliminary analysis of the first 1,218 subjects.
We focused on the associative factors of depressive and
anxiety symptoms as measured by CIS-R, and dispositional
mindfulness as a potential modulator between the risk factors
and CIS-R scores is evaluated. We estimated the sample
with linear regression model using G∗Power3.1. For a small
effect size of 0.02 and 7 predictors (age, gender, education,
MAAS, MoCA, CIRS, loneliness) for CIS-R scores as dependent
variable, 725 subjects are required to achieve a power
of 0.8.
We examined the prevalence of depressive and anxiety
disorders, and correlations between associative factors and the
CIS-R scores. The variables examined included demographic
factors, chronic physical morbidity (CIRS), global cognitive
function (MoCA), dispositional mindfulness (MAAS scores),
and loneliness scores. Variables having potentially significant
associations with CIS-R scores are entered as independent
variables in linear regression analysis. CIS-R scores were the
dependent variable, with interaction effects between MAAS and
risk factors (centered) computed in the regression analysis. To
further explore if MAAS scores are associative factor for mood
symptoms in cognitive compromised individuals, regression
analyses were repeated in CDR 0 (cognitively healthy) and
CDR ≥0.5 (NCD) groups, respectively. SPSS V24 was used to
compute the statistical analyses, with significant level set at p
< 0.05.
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TABLE 1 | Demographic characteristics of sample.
Total CDR 0 CDR 0.5 CDR ≥ 1 P-valueb
(n = 1218) (n = 802) (n = 391) (n = 25)
Age (years) 69.0 ± 6.9 67.3 ± 6.0 71.9 ± 7.4 76.5± 7.6 <0.001
Gender (n, %)a
Male 555 (45.5%) 367 (45.8%) 180 (46.0%) 8 (32.0%) 0.387
Female 663 (54.4%) 435 (54.2%) 211 (54.0%) 17 (68.0%)
Education (years) 8.9 ± 4.3 9.7 ± 4.1 7.4 ± 4.2 5.5 ± 4.0 <0.001
MoCA 24.7 ± 3.9 26.3 ± 2.6 22.0 ± 3.8 15.2 ± 5.3 <0.001
CIS-R 5.0 ± 8.6 4.2 ± 7.8 6.2 ± 7.2 10.4 ± 21.0 <0.001
CIRS 4.1 ± 2.7 3.7 ± 2.2 5.0 ± 3.1 5.6 ± 3.5 <0.001
MAAS 5.3 ± 0.6 5.4 ± 0.5 5.2 ± 0.6 5.0 ± 1.0 <0.001
Loneliness 2.8 ± 1.3 2.7 ± 1.3 2.8 ± 1.3 2.7 ± 0.9 0.335
MoCA, Montreal Cognitive Assessment; CIS-R, Clinical Interview Schedule – revised; CIRS, Cumulative Illness Disease Raring Scale; MAAS, The Mindful Attention Awareness Scale;
Loneliness, 6-item De Jong Gierveld Loneliness Scale; CDR, Clinical Dementia Rating.
aChi Square.
bANOVA, analysis of variance.
RESULTS
Sample Characteristics
In this interim report, 1,218 participants have been assessed
for cognitive function, psychiatric symptoms, and dispositional
mindfulness. The mean age of the sample is 69.0 (SD 6.9) years;
555 (45.5%) were men, with an average education of 8.9 (SD
4.3) years. The average MoCA score was 24.7 (SD 3.9). As for
global cognitive status, 802 (65.7%) was not demented (CDR 0).
Three hundred ninety-one (32%) and 25 (2%) were categorized
as having mild NCD (CDR 0.5) and major NCD (CDR 1 or
more), respectively.
The average MAAS score is 5.3 (SD 0.6), indicating the
range for scoring MAAS is relatively high in this subject sample
(Table 1). Nine hundred and ninety participants (81%) had no
regular mindfulness activities. For those who practice mindful
activities regularly, the average year of practice was 23.4 (SD
18.6). There was no difference in MAAS scores between those
who practiced (5.3, SD 0.6) and did not practice (5.3, SD 0.5)
mindful activities (t-test, p = 0.46). We observed a positive
association between years of mindfulness practice and MAAS
scores (r = 0.17, p = 0.009) and education (r = 0.0.18, p =
0.006). Higher MAAS scores are associated with female gender
(t = 4.99, p < 0.001), older age (r = 0.096, p = 0.001), and
lower CIRS (r = −0.187, p < 0.001). In regression analysis of
demographic factors associated withMAAS scores, only duration
of practice was significant (p= 0.02), while age, gender, and years
of education were not significant (linear regression, R2 = 0.03).
Prevalence of Mood Symptoms and
Association With Dispositional Mindfulness
The average CIS-R scores was 5.0 (SD 8.6). One hundred
forty-three (11.7%) satisfied ICD-10 criteria for one anxiety or
depressive disorder. Of them, 67 (5.5%) had generalized anxiety
disorder (GAD), 30 (2.5%) had depressive disorder, and 52 (4.2%)
had mixed anxiety and depressive disorder, with a proportion
suffering from comorbid mood disorders. The CIS-R scores
TABLE 2 | Clinical correlates of CIS-R scores.
Correlations (r)a P-value
Genderb 4.88*** <0.001
Age (years) 0.002 0.954





MoCA, Montreal Cognitive Assessment; CIS-R, Clinical Interview Schedule – revised;
CIRS, Cumulative Illness Disease Raring Scale; MAAS, The Mindful Attention Awareness
Scale; Loneliness, 6-item De Jong Gierveld Loneliness Scale.
*Significant at p < 0.05. ***Significant at p < 0.001.
aPearson correlations.
bt-test.
were associated with female gender (t = 4.9, p < 0.001), lower
educational attainment (r = −0.07, p = 0.013), lower MoCA
score (r = −0.11, p < 0.001), higher CIRS score (r = 0.23, p <
0.001), higher loneliness (r = 0.07, p = 0.015), and lower MAAS
score (r = −0.35, p < 0.001). Age is not significantly associated
with CIS-R scores (Table 2).
Mood Symptoms and Dispositional
Mindfulness
Female gender, higher CIRS, and lower MAAS scores are
significant factors for higher CIS-R scores (linear regression,
adjusted R2 = 0.439, p < 0.001). MAAS scores interacted with
CIRS on CIS-R scores. Higher level of dispositional mindfulness
attenuated the association between CIRS and CIS-R scores
(1R2 = 0.007, p = 0.001) (Table 3). The regression analysis
was repeated in patients with CDR = 0 and CDR ≥ 0.5
(NCD group), respectively. For CDR 0 group, female gender,
lower MAAS, and higher CIRS scores were associated with
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TABLE 3 | Factors associated with CIS-R scores (All participants).
Model 1a Model 2b
Factors Standardized t P Standardized t P
β β
MAAS −0.34*** −12.43 <0.001 −0.20*** −4.13 <0.001
Female 0.09*** 3.38 0.001 0.09** 3.43 0.001
Education (years) 0.006 0.18 0.854 0.003 0.08 0.934
CIRS 0.19*** 7.10 <0.001 0.87*** 4.17 <0.001
MoCA −0.04 −1.21 0.228 −0.04 −1.23 0.220
Loneliness 0.01 0.55 0.583 0.01 0.32 0.749
MAAS*CIRS −0.68** −3.28 0.001
CIS-R, Clinical Interview Schedule – Revised; CIRS, Cumulative Illness Disease Raring Scale; MAAS, The Mindful Attention Awareness Scale; MoCA, Montreal Cognitive Assessment;
MP Duration, years of mindfulness practice.
*Significant at p < 0.05. **Significant at p < 0.01. ***Significant at p < 0.001.
aLinear regression adjusted R2 = 0.439, p < 0.001.
bLinear regression adjusted R2 =0.447, 1R2 = 0.007 (p = 0.001).
TABLE 4A | Factors associated with CIS-R scores (Stratified with CDR status).
Model 1a Model 2b
Factors Standardized β t P Standardized β t P
MAAS −0.27*** −7.74 <0.001 −0.16* −2.47 0.014
Female 0.08* 2.33 0.020 0.08* 2.41 0.016
Education −0.02 −0.45 0.651 −0.02 −0.47 0.64
CIRS 0.15*** 4.37 <0.001 0.72* 2.25 0.025
Loneliness −0.002 −0.05 0.962 −0.006 −0.18 0.859
MAAS*CIRS −0.56 −1.79 0.07
CDR = 0.
CIS-R, Clinical Interview Schedule – Revised; CIRS, Cumulative Illness Disease Raring Scale; MAAS, The Mindful Attention Awareness Scale; MoCA, Montreal Cognitive Assessment.
*Significant at p < 0.05. ***Significant at p < 0.001.
aLinear regression adjusted R2 = 0.348, p < 0.001.
bLinear regression adjusted R2 = 0.353, 1R2 = 0.004, (p = 0.07).
TABLE 4B | CDR ≥ 0.5.
Model 1a Model 2b
Factors Standardized β t P Standardized β t P
MAAS −0.44*** −10.37 <0.001 −0.28*** −3.58 <0.001
Female 0.13** 3.05 0.002 0.13** 2.97 0.003
Education 0.03* 0.69 0.490 −0.03 0.56 0.578
CIRS 0.25*** 5.93 <0.001 0.97** 3.33 0.001
Loneliness 0.05 1.15 0.252 0.04 0.94 0.346
MAAS*CIRS −0.73* −2.50 0.013
CIS-R, Clinical Interview Schedule – Revised; CIRS, Cumulative Illness Disease Raring Scale; MAAS, The Mindful Attention Awareness Scale; MoCA, Montreal Cognitive Assessment.
*Significant at p < 0.05. **Significant at p < 0.01. ***Significant at p < 0.001.
aLinear regression adjusted R2 = 0.320, p < 0.001.
bLinear regression adjusted R2 = 0.330, 1R2 = 0.011 (p = 0.013).
higher CIS-R (adjusted R2 = 0.348, p < 0.001). Interaction
effect between MAAS and CIRS was not significant in this
group (1R2 = 0.004, p = 0.07). For CDR ≥ 0.5 group,
female gender, higher CIRS, and lower MAAS scores were
associated with higher CIS-R scores (adjusted R2 = 0.320, p <
0.001). Interaction effects between MAAS and CIRS (interaction
effect, 1R2 = 0.011, p = 0.013) groups are shown (Table 4,
Figure 1).
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FIGURE 1 | Relationship between CIS-R (Revised Clinical Interview Scale) and CIRS (Cumulative Illness Rating Scale) at MAAS (Mindful Attention Awareness Scale)
equal to −1 SD, mean and +1 SD.
DISCUSSION
Our findings suggested about one in nine community dwelling
older adults suffered from anxiety and/or depressive disorders
in Hong Kong. This approximated previous local studies
in late life mood disorders and suggested that participants
of this preliminary analysis are representative of the older
population of Hong Kong (23). It is not unexpected that female
gender, poorer physical health, and lower cognitive function
are associated with high risks of depression and anxiety. While
these unfavorable physical and psychosocial risks are well-
recognized, many of these risks are enduring in later life
and difficult to modify. Pharmacological interventions remain
as important treatment options. However, judicious use of
drugs has been limited by comorbid medical conditions and
sensitivity to adverse effects of medication. The challenges
on drug use are of particular concern in people suffering
from NCD.
Dispositional mindfulness is examined as potentially
modifiable factor for mental health in our report. We found that
MAAS scores are associated with lower level of mood symptoms,
as reflected by lower CISR scores. As dispositional mindfulness
possibly represented a “negative” risk factor for mood disorders,
we tried to explore if dispositional mindfulness act through
modulating the association between physical risk factors and
mood symptoms. Our findings suggested that MAAS scores
interacted with chronic medical disease burden on CIS-R scores.
When a person is more “mindful,” the association between
physical symptoms and negative mood states appeared to be
attenuated. MAAS captures a person’s subjective attention
awareness of daily experiences. It may impact on mental health
through different pathways, from enhanced awareness of body
sensation and possibly discomfort, to better emotional control.
The better awareness may also help the individual to derive
strategies in adapting physical limitations caused by chronic
medical illness.
We further stratified the association and modulating effects
of MAAS in different cognitive groups. MAAS and CIRS stayed
as risk and “protective” factors in both cognitively healthy and
impaired groups. The influence of chronic medical morbidity
remained a significant risk factor for depression and anxiety,
while a higher level of MAAS decreased the negative impact
of poor physical state on mood symptoms, as well as being an
independent factor on mood symptoms. The findings gave some
inference that dispositional mindfulness is associated with lower
mood symptoms, part of which may act through moderating the
distress associated with physical morbidity.
Not until recently, MBIs have emerged as a potential
option for the management of depression and anxiety in older
adults. A randomized controlled trial of mindful yoga on 138
Chinese patients with Parkinson’s disease indicated that yoga
intervention was superior to stretching and resistance training
in different mental health outcomes (24). Compared with
cognitive behavioral therapy, which emphasizes on rectification
of interpretation biases and dysfunctional beliefs, MBIs focus on
attention awareness and non-judgmental perception of internal
sensory experiences. The theoretical constructs of MBIs could be
more applicable to older adults who are more likely to be living
with chronic health limitations and unresolvable psychosocial
adversities. The current study offered some support to the
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development of MBIs in people with compromised physical
and cognitive function. Medical morbidity is highly prevalent
in the older population, and chronic body symptoms are highly
distressing. Attentional awareness to everyday experience helped
to reduce preoccupation with negative affect associated with
physical discomfort. It may also lead better attention to physical
conditions and adherence to medical treatment.
This study should be interpreted in the context of its
limitations. First, this is a preliminary report of an ongoing
epidemiological survey. Cross-sectional single assessment only
offers information on association and did not give any directional
or causative information. Second, we only used MAAS score
to evaluate the level of attention awareness. We did not find
differences in MAAS scores between participants who practiced
and did not practice mindful activities. This may be related to
a wide range of duration of practice. On the other hand, we
did find a positive association between MAAS scores and year
of practice. This may suggest that an attitude of mindfulness is
potentially adaptable as a long term lifestyle habit to improve
mindful awareness. We hoped that prospective randomized
controlled trials (RCT) on MBIs in people with mild NCD
would give empirical evidence on its efficacy on mental health.
Third, the sample size for major NCD is limited. This may
limit the interpretation for the group of subjects with clinical
dementia. In a RCT investigating the effect of mindfulness
and cognitive stimulation in subjects with mild to moderate
Alzheimer’s disease, the findings suggested that both mindfulness
and cognitive stimulation showed less deterioration in cognitive
function at 2 years (25). This added support to the development
of MBIs in people with NCDs. Our findings further suggested
that, apart from cognitive abilities, mental health parameters
should also be considered as important outcome measure in
future clinical trials.
In older adults experiencing cognitive decline, MBIs would
serve as a cognitive stimulation paradigm. Attention and
executive function training embedded in the mindful practice
may help people with cognitive impairment to assume more
adaptive functional skills. Mindfulness practice may also improve
mood regulation and mental health outcomes. As suggested by
a recent review, MBIs have a potential for wider utilization as
health promotion strategies in people with cognitive impairment,
but better design clinical trials are required to address
methodological limitations that affect generalizability and clinical
applications (26).
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